198 related articles for article (PubMed ID: 16803456)
1. Inducible nitric oxide synthase activity does not contribute to the maintenance of peripheral vascular tone in patients with heart failure.
Dover AR; Chia S; Ferguson JW; Cruden NL; Megson IL; Fox KA; Newby DE
Clin Sci (Lond); 2006 Oct; 111(4):275-80. PubMed ID: 16803456
[TBL] [Abstract][Full Text] [Related]
2. Inducible nitric oxide synthase activity contributes to the regulation of peripheral vascular tone in patients with cirrhosis and ascites.
Ferguson JW; Dover AR; Chia S; Cruden NL; Hayes PC; Newby DE
Gut; 2006 Apr; 55(4):542-6. PubMed ID: 16299035
[TBL] [Abstract][Full Text] [Related]
3. Abnormal desmopressin-induced forearm vasodilatation in patients with heart failure: dependence on nitric oxide synthase activity.
Rector TS; Bank AJ; Tschumperlin LK; Mullen KA; Lin KA; Kubo SH
Clin Pharmacol Ther; 1996 Dec; 60(6):667-74. PubMed ID: 8988069
[TBL] [Abstract][Full Text] [Related]
4. Activation of inducible NOS in peripheral vessels and outcomes in heart failure patients.
Ishibashi Y; Takahashi N; Tokumaru A; Karino K; Sugamori T; Sakane T; Kodani N; Kunizawa Y; Yoshitomi H; Sato H; Oyake N; Murakami Y; Shimada T
J Card Fail; 2008 Nov; 14(9):724-31. PubMed ID: 18995176
[TBL] [Abstract][Full Text] [Related]
5. Forearm vasoconstriction in response to noradrenaline and NG-monomethyl-L-arginine in essential hypertension.
Kneale BJ; Chowienczyk PJ; Brett SE; Cockcroft JR; Ritter JM
Clin Sci (Lond); 1999 Sep; 97(3):277-82. PubMed ID: 10464052
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis.
Campillo B; Chabrier PE; Pelle G; Sediame S; Atlan G; Fouet P; Adnot S
Hepatology; 1995 Nov; 22(5):1423-9. PubMed ID: 7590658
[TBL] [Abstract][Full Text] [Related]
7. Ageing is associated with impairment of nitric oxide and prostanoid dilator pathways in the human forearm.
Singh N; Prasad S; Singer DR; MacAllister RJ
Clin Sci (Lond); 2002 May; 102(5):595-600. PubMed ID: 11980580
[TBL] [Abstract][Full Text] [Related]
8. Effect of endothelin-1 on endothelium-derived vascular responsiveness in man.
Krum H; Cranswick N; Pellizzer AM
Clin Sci (Lond); 1998 Aug; 95(2):151-6. PubMed ID: 9680496
[TBL] [Abstract][Full Text] [Related]
9. In vivo evidence for nitric oxide-mediated calcium-activated potassium-channel activation during human endotoxemia.
Pickkers P; Dorresteijn MJ; Bouw MP; van der Hoeven JG; Smits P
Circulation; 2006 Aug; 114(5):414-21. PubMed ID: 16864730
[TBL] [Abstract][Full Text] [Related]
10. Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal.
Calver A; Collier J; Moncada S; Vallance P
J Hypertens; 1992 Sep; 10(9):1025-31. PubMed ID: 1328361
[TBL] [Abstract][Full Text] [Related]
11. The effect of arginine vasopressin on endothelin production in the human forearm vascular bed.
Postma CT; Maessen SM; Thien T; Smits P
Neth J Med; 2005 Jun; 63(6):199-204. PubMed ID: 16011011
[TBL] [Abstract][Full Text] [Related]
12. Basal nitric oxide production is impaired in offspring of patients with essential hypertension.
McAllister AS; Atkinson AB; Johnston GD; Hadden DR; Bell PM; McCance DR
Clin Sci (Lond); 1999 Aug; 97(2):141-7. PubMed ID: 10409468
[TBL] [Abstract][Full Text] [Related]
13. Vasodilator prostanoids, but not nitric oxide, may account for skeletal muscle hyperaemia in Type I diabetes mellitus.
Skyrme-Jones RA; O'Brien RC; Meredith IT
Clin Sci (Lond); 2000 Nov; 99(5):383-92. PubMed ID: 11052918
[TBL] [Abstract][Full Text] [Related]
14. Effects of arginine vasopressin and 1-desamino-8-D arginine vasopressin on forearm vasculature of healthy subjects and patients with a V2 receptor defect.
van Lieburg AF; Knoers NV; Monnens LA; Smits P
J Hypertens; 1995 Dec; 13(12 Pt 2):1695-700. PubMed ID: 8903635
[TBL] [Abstract][Full Text] [Related]
15. Reduced agonist-induced endothelium-dependent vasodilation in uremia is attributable to an impairment of vascular nitric oxide.
Passauer J; Pistrosch F; Büssemaker E; Lässig G; Herbrig K; Gross P
J Am Soc Nephrol; 2005 Apr; 16(4):959-65. PubMed ID: 15728785
[TBL] [Abstract][Full Text] [Related]
16. Neuronal nitric oxide synthase regulates basal microvascular tone in humans in vivo.
Seddon MD; Chowienczyk PJ; Brett SE; Casadei B; Shah AM
Circulation; 2008 Apr; 117(15):1991-6. PubMed ID: 18391107
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide and cardiac parasympathetic control in human heart failure.
Chowdhary S; Ng GA; Nuttall SL; Coote JH; Ross HF; Townend JN
Clin Sci (Lond); 2002 Apr; 102(4):397-402. PubMed ID: 11914101
[TBL] [Abstract][Full Text] [Related]
18. Basal production of nitric oxide (NO) and non-NO vasodilators in the forearm microcirculation in Type 2 diabetes: associations with blood pressure and HDL cholesterol.
Woodman RJ; Playford DA; Watts GF
Diabetes Res Clin Pract; 2006 Jan; 71(1):59-67. PubMed ID: 16029909
[TBL] [Abstract][Full Text] [Related]
19. N(G)-monomethyl-L-arginine alters insulin-mediated calf blood flow but not glucose disposal in the elderly.
Meneilly GS; Elliott T; Battistini B; Floras JS
Metabolism; 2001 Mar; 50(3):306-10. PubMed ID: 11230783
[TBL] [Abstract][Full Text] [Related]
20. Baseline blood flow and bradykinin-induced vasodilator responses in the human forearm are insensitive to the cytochrome P450 2C9 (CYP2C9) inhibitor sulphaphenazole.
Passauer J; Büssemaker E; Lässig G; Pistrosch F; Fauler J; Gross P; Fleming I
Clin Sci (Lond); 2003 Oct; 105(4):513-8. PubMed ID: 12826020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
